National Cancer Institute; Amended Notice of Meeting, 9932 [2013-03116]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
9932
Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Healthcare Delivery and
Methodologies
Date: March 6, 2013
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: John Newman, Ph.D.,
Scientific Review Officer, HDM IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
MSC 7770, Bethesda, MD 20892, 301–267–
9270, newmanjh@mail.nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Drug Resistance and Drug
Discovery
Date: March 7–8, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Tera Bounds, DVM, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214,
MSC 7808, Bethesda, MD 20892, 301–435–
2306, boundst@csr.nih.gov
Name of Committee: AIDS and Related
Research Integrated Review Group;
Behavioral and Social Consequences of HIV/
AIDS Study Section
Date: March 7–8, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405
Contact Person: Mark P Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Risk, Prevention and Health
Behavior
Date: March 7–8, 2013
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015
Contact Person: Martha M Faraday, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, 301–435–
3575, faradaym@csr.nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Asthma, COPD, Cystic Fibrosis and
Lung Host Defense Applications
Date: March 7–8, 2013
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
VerDate Mar<15>2010
16:40 Feb 11, 2013
Jkt 229001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 6, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03118 Filed 2–11–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Board of Scientific Advisors,
March 4, 2013, 9:00 a.m. to March 5,
2013, 1:00 p.m., National Institutes of
Health, Building 31, 31 Center Drive,
6th Floor, Conference Rm. 10, Bethesda,
MD, 20892 which was published in the
Federal Register on January 24, 2013, 78
FR 5192.
This meeting is amended to change it
to a one-day meeting to be held on
March 4, 2013, from 9:00 a.m. to 5:00
p.m. The meeting is open to the public.
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R01 Grant
Applications.
Date: March 1, 2013.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Caterina Bianco, MD,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Suite.
8134, Bethesda, MD 20892–8328, 301–496–
7011, biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 6, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03115 Filed 2–11–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 6, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2013–03116 Filed 2–11–13; 8:45 am]
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
25, 2013, 8:00 a.m. to March 25, 2013,
5:00 p.m., Hilton Washington DC
North—Gaithersburg, 620 Perry
Parkway, Gaithersburg, MD, 20877
which was published in the Federal
Register on January 14, 2013, 78 FR
5190.
This notice is being amended to
change the title to ‘‘Novel Imaging
Agents to Expand the Clinical Toolkit’’.
The meeting is closed to the public.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
PO 00000
Frm 00050
Fmt 4703
Sfmt 9990
National Cancer Institute; Amended
Notice of Meeting
Dated: February 6, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03114 Filed 2–11–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Page 9932]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Board of Scientific Advisors, March 4, 2013, 9:00 a.m.
to March 5, 2013, 1:00 p.m., National Institutes of Health, Building
31, 31 Center Drive, 6th Floor, Conference Rm. 10, Bethesda, MD, 20892
which was published in the Federal Register on January 24, 2013, 78 FR
5192.
This meeting is amended to change it to a one-day meeting to be
held on March 4, 2013, from 9:00 a.m. to 5:00 p.m. The meeting is open
to the public.
Dated: February 6, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03116 Filed 2-11-13; 8:45 am]
BILLING CODE 4140-01-P
